MYGN
Myriad Genetics IncCompany with tickers: MYGN
CIK
899923
CUSIP
62855J104
Shares Outstanding
94,448,210
Website
https://www.myriad.com
Investor Relations
https://investor.myriad.com/
13F Activity (30d)
57 filings
54 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Lee N. Newcomer, M.D | Class III director | Appointed | 2026-06-04 |
| Rashmi Kumar | Class III director | Appointed | 2026-06-04 |
| Paul M. Bisaro | Class III director | Appointed | 2026-06-04 |